Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 16.

Journal Article

Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Pluetschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Soekler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter and Eichenauer, Dennis A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia, 36 (2). S. 580 - 583. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buehnen, Ina, Pluetschow, Annette, Kobe, Carsten, Dietlein, Markus, Wendtner, Clemens-Martin, Thorspecken, Sven, Topp, Max S., Mauser, Mareike, von Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Hematol. Oncol., 40 (4). S. 801 - 805. HOBOKEN: WILEY. ISSN 1099-1069

Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Goekbuget, Nicola, Fiedler, Walter, Alakel, Nael, Topp, Max S., Hanoun, Maher, Steffen, Bjoern, Waesch, Ralph, Viardot, Andreas, Nachtkamp, Kathrin, Stelljes, Matthias, Poeck, Hendrik, Vucinic, Vladan, Boell, Boris, Beck, Joachim, Fransecky, Lars, Wendelin, Knut, Schneller, Folker, Faul, Christoph, Buecklein, Veit L., Reiser, Lena, Brueggemann, Monika, Serve, Hubert and Schwartz, Stefan (2022). Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL/T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Reiners, Katrin S., Topp, Max S., Younes, Anas, von Tresckow, Bastian, Hummel, Horst Dieter, Kessler, Joerg, Ravic, Miroslav, Marschner, Jens-Peter, von Strandmann, Elke Pogge and Engert, Andreas (2014). AFM13: an antigen specific immunotherapy for the treatment of CD30+malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL). Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., Hummel, Horst, Reiners, Katrin S., Dietlein, Markus, Kuhnert, Georg, Kessler, Joerg, Buerkle, Carolin, Ravic, Miroslav, Knackmuss, Stefan, Marschner, Jens-Peter, von Strandmann, Elke Pogge, Borchmann, Peter and Engert, Andreas (2015). A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma. Blood, 125 (26). S. 4024 - 4032. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., von Tresckow, Bastian, Hummel, Horst-Dieter, Ravic, Miroslav, Marschner, Jens-Peter and Engert, Andreas (2014). Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients - Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Topp, Max S., Eichenauer, Dennis A., von Tnasckow, Bastian, Hummel, Horst-Dieter, Ravic, Miroslav, Marschner, Jens-Peter and Engert, Andreas (2014). Updated phase I data of AFM13: A bispecific tandem antibody (TandAb) in relapsed/refractory (R/R) Hodgkin lymphoma (HL). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Rothe, Achim, Younes, Anas, Reiners, Katrin S., Dietlein, Markus, Eichenauer, Dennis A., Kessler, Joerg, Topp, Max S., Hummel, Horst, Ravic, Miroslav, Hucke, Christian, von Strandmann, Elke Pogge and Engert, Andreas (2011). A Phase I Study with the Bispecific Anti-CD30 x Anti-CD16A Antibody Construct AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 118 (21). S. 1585 - 1586. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Sasse, Stephanie, Goergen, Helen, Pluetschow, Annette, Boell, Boris, Eichenauer, Dennis A., Fuchs, Michael, Behringer, Karolin, Zijlstra, Josee M., Greil, Richard, Markova, Jana, Topp, Max S., Meissner, Julia, Neubauer, Andreas, Baues, Christian, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2018). Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 36 (25). S. 2603 - 2621. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Thu Mar 28 11:16:28 2024 CET.